These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34368436)
1. Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives. Onwuchuluba EE; Oyetunde OO; Soremekun RO J Patient Exp; 2021; 8():23743735211034338. PubMed ID: 34368436 [TBL] [Abstract][Full Text] [Related]
2. Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence. Chong CC; Redzuan AM; Sathar J; Makmor-Bakry M J Patient Exp; 2021; 8():2374373521996958. PubMed ID: 34179377 [TBL] [Abstract][Full Text] [Related]
3. Patients' perspective of disease and medication adherence for type 2 diabetes in an urban area in Bangladesh: a qualitative study. Islam SM; Biswas T; Bhuiyan FA; Mustafa K; Islam A BMC Res Notes; 2017 Mar; 10(1):131. PubMed ID: 28327202 [TBL] [Abstract][Full Text] [Related]
4. Exploring patient's perspective of barriers to diabetic medication adherence in Jazan, Saudi Arabia, using the social determinants of health model. Khardali A; Aladwani A; Alzahrani F; Madkhali OA; Al Qahtani S; Qadri M; Adawi MD; Hakamy M SAGE Open Med; 2024; 12():20503121241271820. PubMed ID: 39161401 [TBL] [Abstract][Full Text] [Related]
5. A qualitative exploration of barriers to medication adherence among patients with uncontrolled diabetes in Qatar: integrating perspectives of patients and health care providers. Jaam M; Hadi MA; Kheir N; Mohamed Ibrahim MI; Diab MI; Al-Abdulla SA; Awaisu A Patient Prefer Adherence; 2018; 12():2205-2216. PubMed ID: 30410316 [TBL] [Abstract][Full Text] [Related]
6. Barriers and Facilitators of Adherence to Oral Anticancer Medications Among Women with Breast Cancer: A Qualitative Study. Onwusah DO; Ojewole EB; Manyangadze T; Chimbari MJ Patient Prefer Adherence; 2023; 17():2821-2839. PubMed ID: 37953981 [TBL] [Abstract][Full Text] [Related]
7. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. Ogedegbe G; Harrison M; Robbins L; Mancuso CA; Allegrante JP Ethn Dis; 2004; 14(1):3-12. PubMed ID: 15002917 [TBL] [Abstract][Full Text] [Related]
8. Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study. Ho SC; Jacob SA; Tangiisuran B PLoS One; 2017; 12(6):e0179290. PubMed ID: 28614368 [TBL] [Abstract][Full Text] [Related]
9. 'I take the drugs… to make the sickness to move out of me': key populations' and service provider perspectives about facilitators and barriers to ART adherence and retention in care in Nigeria. Dirisu O; Eluwa GIE; Callens S; Adams E; Akinwunmi A; Geibel S; Iyortim I Arch Public Health; 2024 Jun; 82(1):88. PubMed ID: 38886824 [TBL] [Abstract][Full Text] [Related]
10. Patients' perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy. Peláez S; Lamontagne AJ; Collin J; Gauthier A; Grad RM; Blais L; Lavoie KL; Bacon SL; Ernst P; Guay H; McKinney ML; Ducharme FM BMC Pulm Med; 2015 Apr; 15():42. PubMed ID: 25907709 [TBL] [Abstract][Full Text] [Related]
11. Factors Impacting Adherence to Diabetes Medication Among Urban, Low Income Mexican-Americans with Diabetes. Baghikar S; Benitez A; Fernandez Piñeros P; Gao Y; Baig AA J Immigr Minor Health; 2019 Dec; 21(6):1334-1341. PubMed ID: 30798408 [TBL] [Abstract][Full Text] [Related]
12. Barriers to medication taking among Kuwaiti patients with type 2 diabetes: a qualitative study. Jeragh-Alhaddad FB; Waheedi M; Barber ND; Brock TP Patient Prefer Adherence; 2015; 9():1491-503. PubMed ID: 26604702 [TBL] [Abstract][Full Text] [Related]
13. Understanding medication adherence among patients of Turkish descent with type 2 diabetes: a qualitative study. Peeters B; Van Tongelen I; Duran Z; Yüksel G; Mehuys E; Willems S; Remon JP; Boussery K Ethn Health; 2015; 20(1):87-105. PubMed ID: 24588791 [TBL] [Abstract][Full Text] [Related]
14. "Why Am I Not Taking Medications?" Barriers and Facilitators of Diabetes Medication Adherence Across Different Health Literacy Levels. Huang YM; Pecanac KE; Shiyanbola OO Qual Health Res; 2020 Dec; 30(14):2331-2342. PubMed ID: 32723206 [TBL] [Abstract][Full Text] [Related]
15. Medication Adherence Changes in Blacks with Diabetes: A Mixed Methods Study. Rao D; Maurer M; Meyer J; Zhang J; Shiyanbola OO Am J Health Behav; 2020 Mar; 44(2):257-270. PubMed ID: 32019658 [No Abstract] [Full Text] [Related]
16. Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists' perspectives. Kennelty KA; Chewning B; Wise M; Kind A; Roberts T; Kreling D Res Social Adm Pharm; 2015; 11(4):517-30. PubMed ID: 25586885 [TBL] [Abstract][Full Text] [Related]
17. Qualitative Exploration of Barriers to Medication Adherence Among Patients with Uncontrolled Diabetes in Saudi Arabia. Alodhaib G; Alhusaynan I; Mirza A; Almogbel Y Pharmacy (Basel); 2021 Jan; 9(1):. PubMed ID: 33440884 [TBL] [Abstract][Full Text] [Related]
18. The barriers and facilitators people with diabetes from a nonEnglish speaking background experience when managing their medications: a qualitative study. Claydon-Platt K; Manias E; Dunning T J Clin Nurs; 2014 Aug; 23(15-16):2234-46. PubMed ID: 24372586 [TBL] [Abstract][Full Text] [Related]
19. Using the theoretical domains framework to determine the barriers and facilitators to medication adherence in Parkinson's disease. Smith JC; Seage CH; Lane E; James DH Explor Res Clin Soc Pharm; 2023 Sep; 11():100309. PubMed ID: 37583935 [TBL] [Abstract][Full Text] [Related]
20. Barriers and Facilitators of Using Sensored Medication Adherence Devices in a Diverse Sample of Patients With Multiple Myeloma: Qualitative Study. Asfaw AA; Yan CH; Sweiss K; Wirth S; Ramirez VH; Patel PR; Sharp LK JMIR Cancer; 2018 Nov; 4(2):e12. PubMed ID: 30425032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]